XML 204 R163.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Deficiency and Members' Equity - Schedule of Stock Option Activity (Details) (Brooklyn ImmunoTherapeutics, LLC) (10-K) - USD ($)
3 Months Ended 9 Months Ended 10 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Nov. 05, 2018
Options Granted 1,000 2,000  
Options Exercised  
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member]          
Options Outstanding, beginning balance         1,165
Options Granted        
Options Forfeited         (80)
Options Outstanding, ending balance         1,085
Options exercisable         1,085
Weighted Average Exercise Price Per Share Outstanding, beginning balance         $ 208
Weighted Average Exercise Price Per Share Granted        
Weighted Average Exercise Price Per Share Forfeited         300
Weighted Average Exercise Price Per Share Outstanding, ending balance         201
Weighted Average Exercise Price Per Share exercisable         $ 201
Weighted Average Remaining Contractual Life (in years) Outstanding, beginning balance         1 year 6 months
Weighted Average Remaining Contractual Life (in years) Outstanding, ending balance         8 months 12 days
Weighted Average Remaining Contractual Life (in years) exercisable         8 months 12 days
Aggregate Intrinsic Value Outstanding, beginning balance        
Aggregate Intrinsic Value Outstanding, ending balance        
Aggregate Intrinsic Value vested and exercisable